Woensdag cijfers VS o.a. Crossuntry Healthcare en Cytori Therapeutics

Op woensdag 2 maart presenteren onder andere deze Amerikaanse bedrijven hun kwartaal- en of jaarcijfers:

  • ACNB
  • Adverum Biotechnologies
  • Agenus
  • Aimmune Therapeutics
  • Akorn
  • Alamo
  • America First Multifamily Investors LP
  • American Eagle Outfitters
  • Approach Resources
  • Atara Biotherapeutics
  • Best Buy
  • Blue Buffalo Pet Products
  • BMC Stocks
  • Botetourt Bankshares
  • Box
  • Cambium Learning
  • Casella Waste Systems
  • Codexis
  • Cogentix Medical
  • Compass Diversifieds
  • CompX International
  • Conifers
  • CPI Card
  • Crocs
  • Crossuntry Healthcare
  • Cumberland Pharmaceuticals
  • Cytori Therapeutics
  • Dermira
  • DineEquity
  • Donaldsonmpany
  • Edgewater Technology
  • Energy Recovery
  • ENGlobal
  • EV Energy Partners LP
  • Fate Therapeutics
  • Fidus Investment
  • Forestar
  • Fox Factory
  • FS Investment
  • Generalmmunication
  • Getty Realty
  • Glaukos
  • Global Eagle Entertainment
  • Gray Television
  • Greif
  • GTTmmunications
  • GTX
  • Health Insurance Innovations
  • Hilton Grand Vacations
  • Hospitality Properties Trust
  • Huttig Building Products
  • Icahn Enterprises LP
  • ICU Medical
  • IDT
  • Ignite Restaurant
  • Image Sensing Systems
  • Impax Laboratories
  • Inventure Foods
  • Issuer Direct
  • Jernigan Capital
  • Jones Soda
  • Joy Global
  • K2Ms
  • Keryx Biopharmaceuticals
  • Kindred Biosciences
  • Kinsale Capital
  • Kopin
  • Lexington Realty Trust
  • Lincoln Educational Services
  • Lowe'smpanies
  • MBIA
  • Mentor Graphics
  • MYR
  • NACCO Industries
  • NanoString Technologies
  • NeuLion
  • NIIs
  • NN
  • Noodles
  • Northern Oil and Gas
  • Ocera Therapeutics
  • Office Depot
  • Omega Protein
  • OTC Markets
  • Pacira Pharmaceuticals
  • Park Hotels & Resorts
  • Planet Fitness
  • Pure Storage
  • R1 RCM
  • Regenxbio
  • Reis
  • Retrophin

    Samengesteld door Analist redactie i.c.m. Citigate First Financial.

    Analist.nl Nieuwsdienst: +31 084-0032-842
    redactie@analist.nl

    Copyright Analist.nl B.V.
    All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any Newsntent provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.

    • Aandelen USA
    Logoanalist
    Belgische aandelen
    Economische ontwikkelingen
    Lynx
    5 redenen om bij LYNX te beleggen
    Over ons Netwerk Partners Social
    Over AnalistMethodeDisclaimerAdverterenPersContactRSS feedinfo@analist.be Analist.beLinksISINGlossary EuronextVFBDe StandaardPrudena.comAAII.comNASDAQvwd GroupBATS Chi-xBats LinkedinTwitter
    ©2024 Analist. Alle rechten voorbehouden
    Developed and maintained by  Velainn logo